Home › Premaitha to Appeal UK Patent Infringement Ruling in Case Against Illumina

Premaitha to Appeal UK Patent Infringement Ruling in Case Against Illumina

Jan 24, 2018

NEW YORK (GenomeWeb) – Premaitha Health announced today that a UK court will allow the firm to appeal a recent ruling in favor of Illumina in patent infringement litigation between the companies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test

  2. Roche Diagnostics' Revenues Grow 6 Percent in First Nine Months of 2018

  3. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  4. Abbott Q3 Dx Business Grows 43 Percent

  5. FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.